Identifying the Appropriate Patients for Atopic Dermatitis Treatments

2016-12-06 20:34:00
Tags: Atopic Dermatitis,Crisaborole,pediatric eczema,psoriasis,severe Atopic Dermatitis,Ustekinumab,specialty pharmacy

Panelists Peter L. Salgo, MD; Cheryl Allen, BS Pharm, MBA; Ed Pezalla, MD, MPH; Jonathan Silverberg, MD, PhD, MPH; and Jeffrey D. Dunn, PharmD, MBA, discuss factors in identifying appropriate patients for specific atopic dermatitis treatments.